BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 22
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• Press Releases

  Leading Independent Proxy Advisory Firm Glass Lewis Endorses Aptose Plan of Arrangement

  March 23, 2026

   · 

  8 min read
• Press Releases

  BridgeBio to Present Long-Term Efficacy and Safety Data from the ATTRibute-CM OLE Trial at the ACC Annual Scientific Sessions

  March 23, 2026

   · 

  2 min read
• Press Releases

  Cognition Therapeutics to Report Fourth Quarter and Year End 2025 Financial Results

  March 23, 2026

   · 

  5 min read
• Press Releases

  Cardinal Health Appoints Patricia A. Hemingway Hall as Board Chair

  March 23, 2026

   · 

  4 min read
• Press Releases

  NKGen Biotech Reports Combined Phase 1 Troculeucel Data Demonstrating Dose-Responsive Cognitive Improvements and Biomarker Correlations in Alzheimer’s Disease at AD/PD 2026™

  March 23, 2026

   · 

  10 min read
• Press Releases

  ORYZON Announces U.S. Patent Grant Covering Iadademstat Combinations with Venetoclax

  March 23, 2026

   · 

  8 min read
• Press Releases

  Humacyte To Announce 2025 Fourth Quarter and Year End Financial Results and Provide Business Update on March 27, 2026

  March 23, 2026

   · 

  5 min read
• Press Releases

  Sapu Nano to Present Everolimus Toxicology Data at SOT 2026 Annual Meeting

  March 23, 2026

   · 

  5 min read
• Press Releases

  NÖK Therapeutics to Present Long-Term Clinical Data at the 11th Annual Innate Killer Summit

  March 23, 2026

   · 

  2 min read
• Press Releases

  Theriva™ Biologics Announces Positive End-of-Phase 2 Meeting with U.S. FDA Regarding the Design of a Phase 3 Trial of VCN-01 in Metastatic Pancreatic Ductal Adenocarcinoma

  March 23, 2026

   · 

  8 min read